Repeat transurethral resection for non‐muscle‐invasive bladder cancer: a contemporary series

Authors:

Abstract
Objectives: To evaluate the depth of transurethral resections of bladder tumour ( TURBT ), residual cancer rates and up‐staging rates in a contemporary Australian series. Materials and Methods: Specimen reports from a single, major reporting pathology centre, servicing a group of urological oncologists in Sydney were obtained for TURBT s performed between October 2008 and February 2013. We examined the depth of TURBT , rates of repeat‐ TURBT (re‐ TUR ) and residual cancer rates at the 3–6 month check cystoscopy. Results: One thousand and two hundred and nine transurethral resection specimens retrieved during this period were analysed. There were 162 (13.4%) T1 specimens and 631 (52.2%) Ta specimens, 218 (34.5%) of which were high grade. Muscularis propria was present in 506 (41.9%) specimens in total and in 151 (39.7%) of 380 high‐risk specimens (high grade Ta, T1). Of the 380 high‐risk non‐muscle‐invasive tumours, 85 (22.4%) proceeded to re‐ TUR . Of the 48 T1 specimens and 37 Ta high grade specimens that proceeded to re‐ TUR , 7 (14.6%) and 1 (2.7%) respectively were upstaged to muscle‐invasive disease. Rates of residual disease/early recurrence at 3–6 months was significantly better for those with re‐ TUR compared to those without 56.8% vs 82.5% ( P < 0.001) for Ta high grade and 39.6% vs 84% ( P = 0.028) for T1 tumours respectively. Conclusion: Re‐ TUR rates in high‐risk non‐muscle‐invasive bladder cancer are low. However in a contemporary series, the upstaging rates are low, but residual cancer rates high, supporting the need for re‐ TUR in this population.
Funding Information
  • Cancer Institute NSW (10/ECF/2-29)

This publication has 19 references indexed in Scilit: